Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia
E. Leitersdorf*, S. Eisenberg, O. Eliav, Y. Friedlander, N. Berkman, E. J. Dann, D. Landsberger, E. Sehayek, V. Meiner, M. Wurm, J. M. Bard, J. C. Fruchart -, Y. Stein
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review
95Scopus
citations
Fingerprint
Dive into the research topics of 'Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia'. Together they form a unique fingerprint.